Butterfly Network UBS Global Healthcare Conference
Review the key takeaways and the transcript of this earnings call.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Amazing. Okay, thank you. Welcome, everybody. It's Patrick Wood, obviously, on the UBS MedTech team. Appreciate everybody coming here, and excited to have Joe DeVivo here from Butterfly as CEO. Thank you so much for joining us.
Thank you very much for having us.
Just before we came on, we were having this discussion. A lot has changed at Butterfly in the last five years or so, certainly since I've been looking at it. What might be helpful, I think, to level set people is just to give a sense of very high level, big picture, the last few years, what's changed moving from just point-of-care ultrasound, which is still an amazing market, to the broader opportunity set.
Thank you for that. Really appreciate it. We're on this kind of lifelong journey to help democratize imaging, and our whole vision for Butterfly has been, how do we use technology to reduce the cost, improve access to imaging for people around the world? How do we create the opportunity where every doctor and every nurse can have an imaging device just like they have a stethoscope? We're the stethoscope salespeople 40 or 50 years ago. They used to literally, doctors used to put their ears on the chest, and then they had to be convinced by someone that it made sense to have a stethoscope to be able to hear it properly, and then what were the sounds and what did that mean? Of course, we've learned that imaging inside the body is extremely valuable.
But to be able to have the capability of imaging where the patient is, we are seeing just every day lives being saved because things are found early. We are in an amazing evolution. I think we are seeing it is becoming more standard of care in emergency medicine. It is becoming standard of care in the intensive care unit. As the market embraces the concept of physicians and nurses having the ability to image where the patient is, at the same time, the technology is evolving to make it easier and easier. The image quality is improving because our semiconductors are improving exponentially with Moore's Law. We are now having new AI tools come out that make it easier for novices in ultrasound to be able to at least acquire or capture the image.
A lot of things are converging, and now when we look at the semiconductor technology and its improvements, we look at the ability of doing these large language models and creating automation with AI, and then the compute convergence, it is kind of putting us at the center today of imaging because we are liberating our semiconductor for other companies to use. That is really what has changed. We maintain our focus. We are training doctors every day. We are going in with our salespeople into new facilities, putting in software and devices. We are educating through digital activation. We are on the journey of bringing point-of-care ultrasound the standard of care, but we have also now taken a few other paths along the way to diversify ourselves.
Definitely want to get to those. Maybe starting with, I have a soft spot for radiology, but starting with the point-of-care ultrasound.
You touched on it earlier, the unique thing in some ways about ultrasound is the technical challenge for the operator, right? As a ultrasonographer, it can be a difficult thing.
That's right. These are emergency first responders and things like that.
Could you maybe, for people listening in the room, walk them through some of the initial challenges, what that meant for the initial adoption of point-of-care ultrasound, and then you hinted at it with some AI solutions, things about how you've managed to upskill those first responders to being able to use effectively, clinically, a POCUS solution.
Ultrasound's hard. If anyone's looked at an ultrasound image, it's not intuitive. Black and white, grainy, and it's difficult because first of all, you have to have the ability of knowing, mastering human anatomy. So when you place the ultrasound device on the body, you have to actually find the organ that you wish to find. Then when you get there, you need to know what it is you're doing, what it is you're looking at. So those challenges are very hard. There's only 82,000 ultrasonographers in the United States. So if you think about what it takes in order to go get an image, you have to be inpatient, you have to get a patient, you have to make an appointment and go to the hospital. Whereas, doctors are now, what we're doing is we're starting to train them up a single use case.
Like, look, let's just do a pulmonary scan. If you just do this pulmonary scan and you're looking for pneumonia, pulmonary wetness, then you're starting to reduce the significance of the learning curve, and then they will learn one use case after another. But truly, to expand our market and to get it into everyone else's hands, we can't wait for the evolution of everyone learning. Today, about 80% of the medical schools today teach their kids on Butterfly. So they have them either in the lab or now medical schools, just a month ago, I was on stage at a graduation for the Edward Via College of Osteopathic Medicine, and where the dean of the school, after they received their white coat coming into their education, the dean of the school handed them a stethoscope, and I handed them a Butterfly.
160 kids starting off their education with a Butterfly device. That is happening more and more and more commonly now, the stethoscope and the device. All of these kids who are going to come out in 10 or 20 years are going to change the course of medicine. They are going to make the standard of care. Everyone is going to be required to have ultrasound skills, just like they do a stethoscope. We are a public company. You care about every 90 days worth of performance. You are not going to turn around and give me credit for what is going to happen in 20 years. We have to do things to compress the adoption.
The biggest thing to do to compress the adoption are there are many companies, 50 to 100 different independent companies who are developing AI tools that either help the acquisition of an image or the interpretation of an image. You can imagine now, as you said, in emergency services, when they are in an ambulance and they are triaging a patient on the way who is in critical condition on the way to the hospital, you can actually do a cardiac echocardiogram. You can do a cardiac echo. You could do a pulmonary congestion scan. You could do an abdominal scan. You can do these with AI tools that walk people through, place the probe here.
When you place the probe where the AI tells you to place it, the AI tool actually looks at the image, and then based upon the quality image, will tell you, "Hey, move the probe to the left, move the probe to the right, push down, twist it." When you make it easier to acquire an image, then they will send the imaging to the emergency room before the ambulance gets there. When the patient now is being brought out of the ambulance, instead of being waited to be triaged, they go directly to care. There are thousands of use cases. We are working now where we have actually created a HomeCare business where we are helping at-risk providers with patients in nursing homes, because these patients over time are not titrating or they are not getting a more frequent diagnosis.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.
View the full transcript with ProCall participants
2 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
